Open AccessTreatment Benefit on Cerebrospinal Fluid HIV‐1 Levels in the Setting of Systemic Virological Suppression and Failure
Author(s) -
Serena Spudich,
Nicole Lollo,
Teri Liegler,
Steven G. Deeks,
Richard W. Price
Publication year - 2006
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/508750
Subject(s) - cerebrospinal fluid , medicine , viral load , rna , lentivirus , antiretroviral therapy , immunology , sida , drug resistance , inflammation , gastroenterology , virus , viral disease , biology , biochemistry , microbiology and biotechnology , gene
To characterize the effect of partially suppressive combination antiretroviral therapy on cerebrospinal fluid (CSF) human immunodeficiency virus (HIV)-1 RNA levels and CSF inflammation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom